These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 22209892

  • 1. Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.
    Xu X, Chen K, Kobayashi S, Timm D, Liang Q.
    J Pharmacol Exp Ther; 2012 Apr; 341(1):183-95. PubMed ID: 22209892
    [Abstract] [Full Text] [Related]

  • 2. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.
    Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q.
    J Biol Chem; 2010 Jan 01; 285(1):793-804. PubMed ID: 19901028
    [Abstract] [Full Text] [Related]

  • 3. Caloric restriction mimetic 2-deoxyglucose antagonizes doxorubicin-induced cardiomyocyte death by multiple mechanisms.
    Chen K, Xu X, Kobayashi S, Timm D, Jepperson T, Liang Q.
    J Biol Chem; 2011 Jun 24; 286(25):21993-2006. PubMed ID: 21521688
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy.
    Armour SM, Baur JA, Hsieh SN, Land-Bracha A, Thomas SM, Sinclair DA.
    Aging (Albany NY); 2009 Jun 03; 1(6):515-28. PubMed ID: 20157535
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion.
    Gu J, Fan YQ, Zhang HL, Pan JA, Yu JY, Zhang JF, Wang CQ.
    Biochem Pharmacol; 2018 Apr 03; 150():202-213. PubMed ID: 29475062
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
    Gu J, Hu W, Song ZP, Chen YG, Zhang DD, Wang CQ.
    Int Immunopharmacol; 2016 Mar 03; 32():1-7. PubMed ID: 26774212
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.
    Bartlett JJ, Trivedi PC, Yeung P, Kienesberger PC, Pulinilkunnil T.
    Biochem J; 2016 Nov 01; 473(21):3769-3789. PubMed ID: 27487838
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
    Tian W, Yang L, Liu Y, He J, Yang L, Zhang Q, Liu F, Li J, Liu J, Sumi S, Shen Y, Qi Z.
    J Nutr Biochem; 2020 May 01; 79():108132. PubMed ID: 30857673
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction.
    Gu J, Song ZP, Gui DM, Hu W, Chen YG, Zhang DD.
    Cardiovasc Toxicol; 2012 Dec 01; 12(4):341-9. PubMed ID: 22763982
    [Abstract] [Full Text] [Related]

  • 11. Neuregulin-1 attenuates doxorubicin-induced autophagy in neonatal rat cardiomyocytes.
    An T, Huang Y, Zhou Q, Wei BQ, Zhang RC, Yin SJ, Zou CH, Zhang YH, Zhang J.
    J Cardiovasc Pharmacol; 2013 Aug 01; 62(2):130-7. PubMed ID: 23519142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X, Zhu Y, Deng Y, Zhang S, Zhang Q, Zhao B, Li G.
    Toxicology; 2020 Aug 01; 441():152508. PubMed ID: 32525084
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
    Zhang C, Feng Y, Qu S, Wei X, Zhu H, Luo Q, Liu M, Chen G, Xiao X.
    Cardiovasc Res; 2011 Jun 01; 90(3):538-45. PubMed ID: 21278141
    [Abstract] [Full Text] [Related]

  • 16. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A, Cheng Y, Zhang Y, Zhang Q, Wang S, Tian S, Zou Y, Hu K, Ren J, Ge J.
    J Mol Cell Cardiol; 2014 Jun 01; 71():92-104. PubMed ID: 24434637
    [Abstract] [Full Text] [Related]

  • 17. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A, Akolkar G, Ayyappan P, Sharma AK, Singal PK.
    PLoS One; 2017 Jun 01; 12(7):e0179452. PubMed ID: 28678856
    [Abstract] [Full Text] [Related]

  • 18. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
    Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, Kranias EG.
    Circ Res; 2008 Nov 21; 103(11):1270-9. PubMed ID: 18948619
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Programmed Cell Death 1 Prevents Doxorubicin-Induced Apoptosis Through Autophagy Induction in H9c2 Cardiomyocytes.
    Kanno SI, Hara A.
    Cardiovasc Toxicol; 2022 May 21; 22(5):462-476. PubMed ID: 35190965
    [Abstract] [Full Text] [Related]

  • 20. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M, Sala V, De Santis MC, Cimino J, Cappello P, Pianca N, Di Bona A, Margaria JP, Martini M, Lazzarini E, Pirozzi F, Rossi L, Franco I, Bornbaum J, Heger J, Rohrbach S, Perino A, Tocchetti CG, Lima BHF, Teixeira MM, Porporato PE, Schulz R, Angelini A, Sandri M, Ameri P, Sciarretta S, Lima-Júnior RCP, Mongillo M, Zaglia T, Morello F, Novelli F, Hirsch E, Ghigo A.
    Circulation; 2018 Aug 14; 138(7):696-711. PubMed ID: 29348263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.